Skip to content

Clinical trials

Observational Multiple Sclerosis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Observational Country / region: Canada Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20061
20072
20091
20103
20115
20123
20134
20143
20152
20163
20192
20202
20211
20221
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Unknown status3
Active, not recruiting1
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen9
Bayer4
Clinique Neuro-Outaouais4
Innodem Neurosciences3
Novartis Pharmaceuticals3
University of British Columbia3
McGill University2
University of Alberta2
Alpine Immune Sciences, Inc.1
Celestra Health Systems1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis39
Autoimmune Diseases2
Disease Progression2
Fatigue2
Multiple Sclerosis, Relapsing-Remitting2
Arthritis, Rheumatoid1
Autoimmune Diseases of the Nervous System1
Back Pain1
Colitis, Ulcerative1
Coronary Artery Disease1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.